RadNet, Inc. (RDNT) stock
RDNTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3056% above fair value
$76.42+0.38 (+0.50%)
Close on Nov 13, 2026Market cap $6.01BP/E –Yield –
RadNet total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
RadNet's total debt was $1.33B at Sep 30, 2026. For fiscal 2025 it was $1.09B, up 7.2% from the year before. Over ten years it grew 41.7% a year on average. The highest annual figure on record is $1.09B in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.09B | +7.2% |
| FY2024 | Dec 31, 2024 | $1.02B | +22.4% |
| FY2023 | Dec 31, 2023 | $830.04M | -2.5% |
| FY2022 | Dec 31, 2022 | $851.74M | +12.9% |
| FY2021 | Dec 31, 2021 | $754.66M | +15.6% |
| FY2020 | Dec 31, 2020 | $652.70M | 0.0% |
| FY2019 | Dec 31, 2019 | $652.70M | +4.2% |
| FY2018 | Dec 31, 2018 | $626.51M | +3.3% |
| FY2017 | Dec 31, 2017 | $606.46M | -4.6% |
| FY2016 | Dec 31, 2016 | $636.00M | +1800.2% |
| FY2015 | Dec 31, 2015 | $33.47M | +30.4% |
| FY2014 | Dec 31, 2014 | $25.67M | +245.3% |
| FY2013 | Dec 31, 2013 | $7.44M | -23.0% |
| FY2012 | Dec 31, 2012 | $9.65M | +403.7% |
| FY2011 | Dec 31, 2011 | $1.92M | -99.6% |
| FY2010 | Dec 31, 2010 | $481.58M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.33B | +20.9% |
| Q2 FY2026 | Jun 30, 2026 | $1.33B | +20.8% |
| Q1 FY2026 | Mar 31, 2026 | $1.09B | +7.6% |
| Q4 FY2025 | Dec 31, 2025 | $1.09B | +7.2% |
| Q3 FY2025 | Sep 30, 2025 | $1.10B | +7.5% |
| Q2 FY2025 | Jun 30, 2025 | $1.10B | +7.4% |
| Q1 FY2025 | Mar 31, 2025 | $1.01B | +21.0% |
| Q4 FY2024 | Dec 31, 2024 | $1.02B | +22.4% |
| Q3 FY2024 | Sep 30, 2024 | $1.02B | +18.5% |
| Q2 FY2024 | Jun 30, 2024 | $1.03B | +18.8% |
| Q1 FY2024 | Mar 31, 2024 | $834.64M | -3.9% |
| Q4 FY2023 | Dec 31, 2023 | $830.04M | -2.5% |
| Q3 FY2023 | Sep 30, 2023 | $860.35M | +15.3% |
| Q2 FY2023 | Jun 30, 2023 | $864.32M | +15.4% |
| Q1 FY2023 | Mar 31, 2023 | $868.29M | +15.5% |
| Q4 FY2022 | Dec 31, 2022 | $851.74M | +12.9% |
| Q3 FY2022 | Sep 30, 2022 | $746.29M | -1.5% |
| Q2 FY2022 | Jun 30, 2022 | $749.08M | +0.0% |
| Q1 FY2022 | Mar 31, 2022 | $751.87M | +24.8% |
| Q4 FY2021 | Dec 31, 2021 | $754.66M | +15.6% |
| Q3 FY2021 | Sep 30, 2021 | $757.45M | +20.8% |
| Q2 FY2021 | Jun 30, 2021 | $749.08M | +18.0% |
| Q1 FY2021 | Mar 31, 2021 | $602.68M | -16.6% |
| Q4 FY2020 | Dec 31, 2020 | $652.70M | 0.0% |
| Q3 FY2020 | Sep 30, 2020 | $627.18M | -5.3% |
| Q2 FY2020 | Jun 30, 2020 | $634.84M | -5.6% |
| Q1 FY2020 | Mar 31, 2020 | $722.85M | +14.6% |
| Q4 FY2019 | Dec 31, 2019 | $652.70M | +4.2% |
| Q3 FY2019 | Sep 30, 2019 | $662.61M | +13.6% |
| Q2 FY2019 | Jun 30, 2019 | $672.53M | +13.8% |
| Q1 FY2019 | Mar 31, 2019 | $630.87M | +5.3% |
| Q4 FY2018 | Dec 31, 2018 | $626.51M | +3.3% |
| Q3 FY2018 | Sep 30, 2018 | $583.18M | -5.1% |
| Q2 FY2018 | Jun 30, 2018 | $590.84M | -5.5% |
| Q1 FY2018 | Mar 31, 2018 | $599.15M | -5.1% |
| Q4 FY2017 | Dec 31, 2017 | $606.46M | -4.6% |
| Q3 FY2017 | Sep 30, 2017 | $614.77M | – |
| Q2 FY2017 | Jun 30, 2017 | $625.34M | – |
| Q1 FY2017 | Mar 31, 2017 | $631.25M | – |
| Q4 FY2016 | Dec 31, 2016 | $636.00M | – |
See a number that looks wrong?